-
Nobel Prize-Winning Scientist Explains Why New Study in New England Journal of Medicine May Point To Nitric Oxide as Successful Treatment For COVID-19
prnewswire
June 09, 2020
Although the recent study "Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19" by Ackermann, et al does not include any mention of nitric oxide, many of the world's leading researchers and scientists agree that ...
-
FDA Allows Patients to use VERO’s Nitric Oxide at Home
contractpharma
March 27, 2020
Genosyl DS system facilitates outpatient use of inhaled nitric oxide in the treatment of cardiopulmonary symptoms associated with COVID-19.
-
EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus
prnewswire
March 18, 2020
EmphyCorp Inc., a Private Corporation, is proud to announce that EmphyCorp Rx N115 Non-Steroidal Nasal Spray with no known side effects for Pulmonary Fibrosis, Cystic Fibrosis ...
-
Circassia prepares for potential US launch of nitric oxide product
pharmaphorum
February 19, 2019
UK biotech Circassia has said that its partner AIT Therapeutics has held a meeting with the FDA that paves the way for premarket approval of its nitric oxide product for newborn babies with respiratory failure, AirNOvent.
-
Novan Extends Technical Production Capacity and Reaches Agreement with Orion Corporation
pharmafocusasia
November 28, 2018
Novan, Inc. today announced that the Company has established a strategic alliance with Orion Corporation, a Finnish full-scale pharmaceutical company with broad experience in manufacturing.....
-
Mallinckrodt Initiates Nitric Oxide Gas Study
americanpharmaceuticalreview
August 03, 2018
Mallinckrodt has initiated a company-sponsored, experimental, proof-of-concept study of nitric oxide gas with ex-vivo lung perfusion compared to lung perfusion alone in human lung transplants.....